All In Biotech

Drug Trial Radar · NCT00733226

Effect of OM-85 BV on Wheezing Related Morbidity in Children With Recurrent Wheezing

Phase IV Study of Effect of OM-85 BV (Broncho-Vaxom) on Wheezing Related Morbidity in Children With Recurrent Wheezing

Last checked: Nov 19, 2026Latest source record: Jul 16, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

80

Actual

Start

Aug 2007

Primary completion

Sep 2008

Study completion Oct 2008

Sponsor

Lead sponsor
Kecioren Education and Training HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 13, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Prevention
Who can join
All sexes, from 6 months, up to 6 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether OM-85 BV (Broncho-Vaxom)has any effect on respiratory infections, infection related wheezing attacks, beta-2 agonist use, duration of attacks and effect on serum cytokine levels.

Conditions

  • Asthma

Interventions

  • OM-85 BV (Broncho-Vaxom)Drug

    3.5 mg capsule, 1 capsule per day for first 10 day of the month, for 3 months

  • OM-85 BV (placebo)Drug

    3.5 mg oral placebo capsule, 1 placebo capsule per day for first 10 days of the months for 3 months

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Rate of Wheezing AttacksTime frame: 12 months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Kecioren Education and Training Hospital

    Ankara, Kec.oren, Turkey (Türkiye)

  • Keçiören Education and Training Hospital

    Ankara, Keçiören, Turkey (Türkiye)

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.